My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 240

    1.

    Pantoprazole-induced thrombocytopenia.

    Watson TD, Stark JE, Vesta KS.

    Ann Pharmacother. 2006 Apr;40(4):758-61. Epub 2006 Mar 28.PMID: 16569810 [PubMed - indexed for MEDLINE]Related articles

    2.

    Acute interstitial nephritis due to pantoprazole.

    Ra A, Tobe SW.

    Ann Pharmacother. 2004 Jan;38(1):41-5.PMID: 14742791 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.

    van Zyl J, van Rensburg C, Vieweg W, Fischer R.

    Digestion. 2004;70(1):61-9. Epub 2004 Aug 5.PMID: 15297779 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pantoprazole-induced acute interstitial nephritis.

    Moore I, Sayer JA, Nayar A, Ahmed S, Tapson JS.

    J Nephrol. 2004 Jul-Aug;17(4):580-1.PMID: 15372423 [PubMed - indexed for MEDLINE]Related articles

    5.

    [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole]

    Leonhardt U, Ritzel U, Ramadori G.

    Internist (Berl). 1996 Sep;37(9):944-9; discussion 949. German. No abstract available. PMID: 8964694 [PubMed - indexed for MEDLINE]Related articles

    6.

    Safety of proton pump inhibitors--an overview.

    Arnold R.

    Aliment Pharmacol Ther. 1994;8 Suppl 1:65-70. Review.PMID: 8180297 [PubMed - indexed for MEDLINE]Related articles

    7.

    A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.

    Labenz J, Petersen KU, Rösch W, Koelz HR.

    Aliment Pharmacol Ther. 2003 Apr;17(8):1015-9.PMID: 12694083 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Apparent anaphylaxis associated with pantoprazole.

    Gratacós L, Soy D, Lluís M, López B, Nicolás JM, Codina C, Nogué S, Ribas J.

    Am J Health Syst Pharm. 2005 Jul 1;62(13):1388-9. No abstract available. PMID: 15972383 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers.

    Miner PB Jr, Tutuian R, Castell DO, Liu S, Sostek MB.

    Clin Ther. 2006 May;28(5):725-33.PMID: 16861094 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.

    Regula J, Butruk E, Dekkers CP, de Boer SY, Raps D, Simon L, Terjung A, Thomas KB, Lühmann R, Fischer R.

    Am J Gastroenterol. 2006 Aug;101(8):1747-55. Epub 2006 Jun 30.PMID: 16817839 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Financial restrictions in health care systems could affect treatment quality of GERD-patients]

    Gillessen A, Schöffel L, Naumburger A.

    Z Gastroenterol. 2006 May;44(5):379-85. German. PMID: 16688654 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction.

    Ferron GM, Preston RA, Noveck RJ, Pockros P, Mayer P, Getsy J, Turner M, Abell M, Paul J.

    Clin Ther. 2001 Aug;23(8):1180-92.PMID: 11558857 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

    Lew EA, Pisegna JR, Starr JA, Soffer EF, Forsmark C, Modlin IM, Walsh JH, Beg M, Bochenek W, Metz DC.

    Gastroenterology. 2000 Apr;118(4):696-704.PMID: 10734021 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.

    Miehlke S, Madisch A, Kirsch C, Lindner F, Kuhlisch E, Laass M, Knoth H, Morgner A, Labenz J.

    Aliment Pharmacol Ther. 2005 Apr 15;21(8):963-7.PMID: 15813831 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Recurrent anaphylaxis linked to pantoprazole.

    Kollmeier AP, Eddleston J, Zuraw BL, Christiansen SC.

    J Allergy Clin Immunol. 2004 Oct;114(4):975-7. No abstract available. PMID: 15480345 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.

    Becker TL, Maróstica M, Ribeiro ML, de Mendonça S, Gambero A, Pedrazzoli J Jr.

    Int Immunopharmacol. 2004 Aug;4(8):1051-7.PMID: 15222979 [PubMed - indexed for MEDLINE]Related articles

    17.

    Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.

    Sennaroglu E, Karakan S, Kayatas M, Akdur S, Genc H, Karakan T, Ucler R, Ozisler C, Urun Y.

    Dig Dis Sci. 2006 Jan;51(1):121-2. No abstract available. PMID: 16416223 [PubMed - indexed for MEDLINE]Related articles

    18.

    Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases.

    Brunner G, Athmann C, Boldt JH.

    Dig Dis Sci. 2001 May;46(5):993-6.PMID: 11341670 [PubMed - indexed for MEDLINE]Related articles

    19.

    Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.

    Härtter S, Connemann B, Schönfeldt-Lecuona C, Sachse J, Hiemke C.

    J Clin Psychopharmacol. 2004 Oct;24(5):568-71. No abstract available. PMID: 15349025 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Drug interactions. Proton pump inhibitors II]

    Zaigler M.

    Internist (Berl). 1998 Sep;39(9):978-9. German. No abstract available. PMID: 9788120 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity